Gregory M Vercellotti

Vercellotti, G. M. & Belcher, J. D.

7/1/02 → 6/30/12

Project: Research project

Proposal for the study of PEG-hemoglobin in transgenic s

Sangart

1/1/10 → 6/30/13

Project: Research project

Vascular Pathobiology of Sickle Cell Disease

Hebbel, R. P., Belcher, J. D., Bischof, J. C., Huo, Y., Steer, C. J. & Vercellotti, G. M.

NIH NAT INST OF NEURO DISORDERS & STROKE

9/1/97 → 8/31/13

Project: Research project

Pathogenesis of Cognitive/Neurologic Deficits in Central

John, C. & Vercellotti, G. M.

4/15/08 → 1/14/14

Project: Research project

Non-viral gene therapy for sickle cell anemia

Hebbel, R. P., Kren, B. J., Steer, C. J. & Vercellotti, G. M.

National Institutes of Health

8/1/09 → 4/30/14

Project: Research project

Neurodevelopmental Outcomes in Children with Severe Mala

John, C., Cusick, S., Georgieff, M. K., Hodges, J. S., Kroupina, M., Park, G. & Vercellotti, G. M.

NIH NAT INST OF NEURO DISORDERS & STROKE

1/15/14 → 12/31/14

Project: Research project

Proposal for the study of fucosylation inhibitor SGD-208

Seattle Genetics, Inc.

7/1/12 → 6/30/16

Project: Research project

Hematology Research Training Program

7/1/12 → 6/30/16

Project: Research project

Proposal to Explore Phosphodiesterase Inhibitors in Sick

CYDAN DEVELOPMENT, INC.

3/31/15 → 6/30/16

Project: Research project

Biogen Idec MA Inc SRA

BIOGEN INC

10/2/14 → 6/30/16

Project: Research project

Heme toxicity and vaso-occlusion in sickle cell disease

Vercellotti, G. M., Belcher, J. D., Hebbel, R. P. & Steer, C. J.

9/1/12 → 1/31/17

Project: Research project

Oral Carbon Monoxide Therapeutic to Prevent Sickle Cell

HILLHURST BIOPHARMACEUTICALS, INC.

7/1/16 → 6/30/17

Project: Research project

Hematology Research Training Program

National Institutes of Health

7/1/16 → 6/30/17

Project: Research project

Targeting mechanisms contributing to vascular dysfunction and pain in sickle cell disease

Gupta, K., Belcher, J. D., Guedes, A. & Vercellotti, G. M.

4/4/19 → 6/30/19

Project: Research project

HBI-002 to Prevent Vaso-Occlusive Crises in Sickle Cell Disease

HILLHURST BIOPHARMACEUTICALS, INC.

9/20/18 → 6/30/19

Project: Research project

A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients with Autoimmune Hemolytic Anemia and Immune Thrombocytopenia

Vercellotti, G. M. & Mazepa, M.

KEZAR LIFE SCIENCES, INC

8/20/19 → 9/1/20

Project: Research project

Circulating Endothelial Cells and Microvesicles as Biomarkers for Gene Therapy in Sickle Cell Disease

Belcher, J. D., Beckman, J. D., Hebbel, R. P. & Vercellotti, G. M.

9/20/19 → 6/30/21

Project: Research project

Heme toxicity and vaso-occlusion in sickle cell disease

Vercellotti, G. M., Belcher, J. D., Hebbel, R. P. & Steer, C. J.

2/1/17 → 1/31/22

Project: Research project

Hematology Research Training Program

National Institutes of Health

7/1/17 → 6/30/22

Project: Research project

Redefining clinical viscosity in sickle cell disease by leveraging microfluidic technologies

Wood, D. K., Datta, Y. H. & Vercellotti, G. M.

Emory University

9/1/18 → 8/31/22

Project: Research project

Mitobridge Study of HO-1 Induction in Sickle Cell Diseas

MITOBRIDGE, INC

8/1/18 → 9/30/22

Project: Research project

PoC studies for Placenta Growth Factor Inhibition as a therapeutic approach in SCD

University of California at Irvine

CSL BEHRING GMBH

6/27/22 → 12/27/22

Project: Research project

Targeting mechanisms contributing to vascular dysfunction and pain in sickle cell disease

Guedes, A., Belcher, J. D. & Vercellotti, G. M.

12/5/19 → 3/31/23

Project: Research project

MT2017-42: A Phase 1/2, Open-label, Single-arm Study to

Vercellotti, G. M. & Smith, A. R.

Sangamo Therapeutics, Inc.

5/15/18 → 5/14/23

Project: Research project

A Phase 2, Open-Label Study of INCB050465 in Participants WithAutoimmune Hemolytic Anemia

Vercellotti, G. M. & Mazepa, M.

Incyte Corporation

1/10/19 → 4/30/24

Project: Research project

Anti-G-CSFR Monoclonal Antibodies to Treat Sickle Cell Disease

CSL BEHRING GMBH

6/30/21 → 6/30/24

Project: Research project

Developing a multiscale understanding of biophysical processes in sickle cell disease

Wood, D. K., Beckman, J. D., Datta, Y. H., Odde, D. J. & Vercellotti, G. M.

7/1/21 → 5/31/25

Project: Research project

ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria(AHP)

Alnylam Pharmaceuticals, Inc.

2/15/21 → 2/28/26

Project: Research project

An observational long-term safety and efficacy followup study after ex-vivo gene therapy with BIVV003 inparticipants with severe sickle cell disease (SCD) orwith ST-400 in participants with transfusion-dependent??-thalassemia (TDT) with autologous hem

SANOFI-AVENTIS US

7/21/21 → 7/31/26

Project: Research project

Hematology Research Training Program